Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

ITOS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.50%

Insider Buying (Last 12 Months): $38,650.00

Insider Selling (Last 12 Months): $0.00

iTeos Therapeutics Insider Trading History Chart

iTeos Therapeutics Share Price & Price History

^$7.90

▲ +0.02 (0.25%)

As of 11/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

iTeos Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/19/2024	Matthew Gall	CFO	Buy	5,000	$7.73	$38,650.00	65,429
10/12/2023	Matthew Gall	CFO	Buy	5,000	$8.37	$41,850.00	19,429
8/23/2023	Boxer Capital, Llc	Insider	Sell	350,000	$16.26	$5,691,000.00	1,804,058
6/9/2022	David Hallal	Director	Sell	1,171	$19.51	$22,846.21
5/11/2022	Aaron I Davis	Director	Sell	338,000	$18.25	$6,168,500.00	2,154,058
5/9/2022	Aaron I Davis	Director	Sell	225,000	$23.40	$5,265,000.00	2,592,058
5/2/2022	Aaron I Davis	Director	Sell	100,000	$27.49	$2,749,000.00	2,817,058
4/28/2022	Aaron I Davis	Director	Sell	150,000	$27.40	$4,110,000.00	3,042,058
4/18/2022	Michel Detheux	CEO	Sell	11,500	$31.87	$366,505.00	26,263
3/22/2022	Aaron I Davis	Director	Buy	30,000	$32.28	$968,400.00
3/22/2022	Michel Detheux	CEO	Sell	18,437	$34.17	$629,992.29
3/17/2022	Boxer Capital, Llc	Major Shareholder	Sell	575,201	$35.25	$20,275,835.25
3/11/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$36.01	$126,035.00
3/1/2022	Yvonne McGrath	Insider	Sell	10,000	$36.76	$367,600.00
2/23/2022	Michel Detheux	CEO	Sell	14,500	$34.34	$497,930.00
2/11/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$35.85	$125,475.00
1/25/2022	Michel Detheux	CEO	Sell	14,500	$35.68	$517,360.00
1/14/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$39.32	$137,620.00
1/4/2022	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	128,550	$42.66	$5,483,943.00
1/3/2022	Detlev Biniszkiewicz	Director	Sell	3,500	$51.90	$181,650.00
1/3/2022	Joanne Jenkins Lager	Insider	Sell	7,000	$51.90	$363,300.00
12/27/2021	Matthew Gall	CFO	Sell	5,000	$46.45	$232,250.00
12/22/2021	Michel Detheux	CEO	Sell	16,163	$45.03	$727,819.89
12/20/2021	David Hallal	Director	Sell	50,000	$43.57	$2,178,500.00
12/20/2021	Michel Detheux	CEO	Sell	9,111	$43.94	$400,337.34
12/17/2021	Joanne Jenkins Lager	Insider	Sell	7,000	$41.00	$287,000.00
12/10/2021	Joanne Jenkins Lager	Insider	Sell	3,500	$34.50	$120,750.00
12/6/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,208	$32.59	$332,678.72
12/3/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	20,167	$34.79	$701,609.93
12/1/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	12,395	$34.28	$424,900.60
11/29/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,371	$34.49	$357,695.79
11/26/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	12,674	$35.75	$453,095.50
11/24/2021	Ansbert Gadicke	Major Shareholder	Sell	60,808	$36.29	$2,206,722.32
11/23/2021	Michel Detheux	CEO	Sell	14,500	$36.08	$523,160.00
11/22/2021	Ansbert Gadicke	Major Shareholder	Sell	35,333	$37.52	$1,325,694.16

Tesla Execs are Freaking Out

From Angel Publishing | Ad

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Click here to get the details.

SEC Filings (Institutional Ownership Changes) for iTeos Therapeutics (NASDAQ:ITOS)

97.16% of iTeos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

iTeos Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	113,211	$1.16M	0.0%	-7.4%	0.310%
11/16/2024	Geode Capital Management LLC	640,350	$6.54M	0.0%	+3.2%	1.753%
11/15/2024	Barclays PLC	113,211	$1.16M	0.0%	-7.4%	0.310%
11/15/2024	Public Employees Retirement System of Ohio	28,826	$0.29M	0.0%	-21.6%	0.079%
11/15/2024	XTX Topco Ltd	18,207	$0.19M	0.0%	N/A	0.050%
11/15/2024	Wellington Management Group LLP	105,769	$1.08M	0.0%	+20.9%	0.290%
11/15/2024	State Street Corp	1,175,353	$12M	0.0%	+21.9%	3.218%
11/15/2024	RA Capital Management L.P.	3,184,711	$32.52M	0.4%	-9.5%	8.718%
11/15/2024	Readystate Asset Management LP	169,819	$1.73M	0.0%	+97.2%	0.465%
11/15/2024	Point72 DIFC Ltd	2,999	$31K	0.0%	N/A	0.008%
11/15/2024	Jacobs Levy Equity Management Inc.	205,863	$2.10M	0.0%	+16.8%	0.564%
11/15/2024	Clearline Capital LP	167,417	$1.71M	0.1%	+6.7%	0.458%
11/14/2024	Verition Fund Management LLC	26,798	$0.27M	0.0%	-15.5%	0.073%
11/14/2024	Vestal Point Capital LP	1,025,000	$10.47M	0.8%	-41.4%	2.807%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	56,507	$0.58M	0.0%	-4.0%	0.155%
11/14/2024	Stonepine Capital Management LLC	30,000	$0.31M	0.2%	N/A	0.082%
11/12/2024	Algert Global LLC	256,139	$2.62M	0.1%	+92.0%	0.701%
11/12/2024	Eagle Asset Management Inc.	151,649	$1.55M	0.0%	-7.7%	0.415%
11/12/2024	Charles Schwab Investment Management Inc.	222,135	$2.27M	0.0%	+3.9%	0.608%
11/12/2024	Massachusetts Financial Services Co. MA	23,662	$0.24M	0.0%	N/A	0.065%
11/9/2024	Intech Investment Management LLC	15,085	$0.15M	0.0%	N/A	0.041%
11/7/2024	Quest Partners LLC	11,020	$0.11M	0.0%	+914.7%	0.030%
11/6/2024	Empowered Funds LLC	65,767	$0.67M	0.0%	+5.4%	0.180%
11/5/2024	Victory Capital Management Inc.	95,240	$0.97M	0.0%	-13.7%	0.261%
11/5/2024	GSA Capital Partners LLP	25,787	$0.26M	0.0%	N/A	0.071%
10/28/2024	US Bancorp DE	12,076	$0.12M	0.0%	+206.0%	0.033%
10/25/2024	China Universal Asset Management Co. Ltd.	7,024	$72K	0.0%	+60.4%	0.019%
10/16/2024	nVerses Capital LLC	2,500	$26K	0.0%	+212.5%	0.007%
10/11/2024	Creative Planning	19,636	$0.20M	0.0%	+6.5%	0.054%
10/10/2024	Exchange Traded Concepts LLC	13,840	$0.14M	0.0%	-31.7%	0.038%
10/3/2024	SG Americas Securities LLC	12,358	$0.13M	0.0%	N/A	0.034%
8/16/2024	Clearline Capital LP	156,894	$2.33M	0.1%	N/A	0.434%
8/16/2024	Algert Global LLC	133,409	$1.98M	0.1%	+4.8%	0.369%
8/15/2024	The Manufacturers Life Insurance Company	11,071	$0.16M	0.0%	+6.6%	0.031%
8/15/2024	Millennium Management LLC	241,305	$3.58M	0.0%	-72.7%	0.668%
8/15/2024	AQR Capital Management LLC	29,298	$0.44M	0.0%	-66.0%	0.081%
8/14/2024	Squarepoint Ops LLC	19,636	$0.29M	0.0%	-66.4%	0.054%
8/12/2024	Hsbc Holdings PLC	12,577	$0.19M	0.0%	-70.5%	0.035%
8/9/2024	Renaissance Technologies LLC	559,600	$8.30M	0.0%	-22.0%	1.549%
8/9/2024	Dimensional Fund Advisors LP	908,329	$13.48M	0.0%	+14.8%	2.515%
8/8/2024	Federated Hermes Inc.	1,805	$27K	0.0%	-32.9%	0.005%
8/8/2024	American Century Companies Inc.	46,322	$0.69M	0.0%	+26.5%	0.128%
8/6/2024	Los Angeles Capital Management LLC	25,398	$0.38M	0.0%	-13.6%	0.070%
8/6/2024	Candriam S.C.A.	509,303	$7.56M	0.0%	N/A	1.410%
8/5/2024	Victory Capital Management Inc.	110,389	$1.64M	0.0%	+17.7%	0.306%
8/1/2024	Rhumbline Advisers	44,861	$0.67M	0.0%	+8.5%	0.124%
7/29/2024	Panagora Asset Management Inc.	131,553	$1.95M	0.0%	+8.9%	0.364%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	11,998	$0.18M	0.0%	+35.9%	0.033%
7/26/2024	Allspring Global Investments Holdings LLC	3,776	$56K	0.0%	-61.3%	0.010%
7/26/2024	Bank of New York Mellon Corp	121,250	$1.80M	0.0%	+4.7%	0.336%
5/17/2024	Ikarian Capital LLC	101,325	$1.38M	0.2%	-70.8%	0.281%
5/16/2024	California State Teachers Retirement System	23,393	$0.32M	0.0%	-5.6%	0.065%
5/16/2024	Jacobs Levy Equity Management Inc.	504,545	$6.88M	0.0%	-5.6%	1.397%
5/16/2024	Kennedy Capital Management LLC	145,734	$1.99M	0.0%	N/A	0.403%
5/15/2024	Public Employees Retirement System of Ohio	39,003	$0.53M	0.0%	+4.9%	0.108%
5/10/2024	Acadian Asset Management LLC	244,712	$3.34M	0.0%	N/A	0.680%
5/10/2024	Vanguard Group Inc.	1,500,602	$20.47M	0.0%	+0.6%	4.172%
5/7/2024	Susquehanna Portfolio Strategies LLC	101,775	$1.39M	0.0%	-1.3%	0.283%
5/7/2024	SG Americas Securities LLC	9,614	$0.13M	0.0%	-34.8%	0.027%
5/7/2024	Empowered Funds LLC	57,917	$0.79M	0.0%	-52.2%	0.161%
4/30/2024	Allspring Global Investments Holdings LLC	9,767	$0.13M	0.0%	-47.0%	0.027%
4/29/2024	China Universal Asset Management Co. Ltd.	6,877	$94K	0.0%	+66.1%	0.019%
4/18/2024	Allspring Global Investments Holdings LLC	9,767	$0.13M	0.0%	-47.0%	0.027%
4/5/2024	Los Angeles Capital Management LLC	29,398	$0.40M	0.0%	N/A	0.082%
2/20/2024	Readystate Asset Management LP	141,791	$1.55M	0.1%	+34.2%	0.396%
2/14/2024	Sectoral Asset Management Inc.	220,056	$2.41M	1.0%	+41.9%	0.615%
2/13/2024	Aristides Capital LLC	14,360	$0.16M	0.1%	N/A	0.040%
2/12/2024	Hsbc Holdings PLC	55,956	$0.61M	0.0%	+328.1%	0.156%
2/9/2024	Quest Partners LLC	8,236	$90K	0.0%	N/A	0.023%
2/9/2024	Trexquant Investment LP	61,658	$0.68M	0.0%	+83.8%	0.172%
2/9/2024	Dynamic Technology Lab Private Ltd	47,461	$0.52M	0.1%	+357.2%	0.133%
2/8/2024	Panagora Asset Management Inc.	124,511	$1.36M	0.0%	-14.9%	0.348%
2/8/2024	Massachusetts Financial Services Co. MA	75,846	$0.83M	0.0%	-3.1%	0.212%
2/7/2024	Jump Financial LLC	58,056	$0.64M	0.0%	N/A	0.162%
2/7/2024	Gladius Capital Management LP	3,131	$34K	0.0%	+48.7%	0.009%
2/6/2024	AJOVista LLC	5,233	$57K	0.1%	N/A	0.015%
2/6/2024	Swiss National Bank	45,900	$0.50M	0.0%	-9.3%	0.128%
2/5/2024	Victory Capital Management Inc.	79,793	$0.87M	0.0%	-19.5%	0.223%
2/5/2024	Russell Investments Group Ltd.	39,508	$0.43M	0.0%	+66.3%	0.110%
2/1/2024	Signaturefd LLC	4,481	$49K	0.0%	+268.5%	0.013%
1/31/2024	Federated Hermes Inc.	2,944	$32K	0.0%	+4,648.4%	0.008%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	8,826	$97K	0.0%	+53.3%	0.025%
1/30/2024	Strs Ohio	10,800	$0.12M	0.0%	-28.5%	0.030%
1/30/2024	Vontobel Holding Ltd.	220,056	$2.41M	0.0%	+41.9%	0.615%
1/25/2024	Allspring Global Investments Holdings LLC	18,412	$0.20M	0.0%	+4,094.1%	0.051%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	11,129	$0.12M	0.0%	-19.4%	0.031%
1/24/2024	China Universal Asset Management Co. Ltd.	4,140	$45K	0.0%	+348.1%	0.012%
1/12/2024	SG Americas Securities LLC	14,750	$0.16M	0.0%	N/A	0.041%
1/5/2024	Exchange Traded Concepts LLC	11,379	$0.13M	0.0%	+34.0%	0.032%
12/18/2023	Vanguard Group Inc.	1,813,759	$19.86M	0.0%	+2.3%	5.069%
12/6/2023	Citigroup Inc.	86,334	$0.95M	0.0%	-63.2%	0.241%
11/17/2023	Jacobs Levy Equity Management Inc.	459,712	$5.03M	0.0%	-6.3%	1.285%
11/15/2023	Sectoral Asset Management Inc.	155,075	$1.70M	0.3%	+5.8%	0.433%
11/15/2023	Adage Capital Partners GP L.L.C.	20,000	$0.22M	0.0%	N/A	0.056%
11/14/2023	683 Capital Management LLC	810,000	$8.87M	0.7%	+38.5%	2.264%
11/14/2023	Deerfield Management Company L.P. Series C	723,000	$7.92M	0.2%	N/A	2.021%
11/14/2023	Trexquant Investment LP	33,549	$0.37M	0.0%	+10.8%	0.094%
11/14/2023	Profund Advisors LLC	15,429	$0.17M	0.0%	-8.3%	0.043%
11/13/2023	Algert Global LLC	96,180	$1.05M	0.0%	+131.3%	0.269%
11/13/2023	WINTON GROUP Ltd	33,433	$0.37M	0.0%	+173.8%	0.093%

Data available starting January 2016

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonists that is in Phase 1/2a clinical trials to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment; and EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to inhibit the immunosuppressive activity of adenosine and restore immune cell proliferation is in Phase 1 clinical trials. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $7.90

$7.66

$7.91

50 Day Range

MA: $9.96

$7.88

$16.90

52 Week Range

Now: $7.90

$7.66

$18.75

Volume

444,714 shs

Average Volume

443,252 shs

Market Capitalization

$288.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

Who are the company insiders with the largest holdings of iTeos Therapeutics?: iTeos Therapeutics' top insider shareholders include:
Boxer Capital, Llc (Insider)
Matthew Gall (CFO)
Learn More about top insider investors at iTeos Therapeutics.
Who are the major institutional investors of iTeos Therapeutics?: iTeos Therapeutics' top institutional shareholders include:
RA Capital Management L.P. — 8.72%
State Street Corp — 3.22%
Vestal Point Capital LP — 2.81%
Geode Capital Management LLC — 1.75%
Algert Global LLC — 0.70%
Charles Schwab Investment Management Inc. — 0.61%
Learn More about top institutional investors of iTeos Therapeutics stock.
Which institutional investors are selling iTeos Therapeutics stock?: Within the last quarter, ITOS stock was sold by these institutional investors:
Vestal Point Capital LP
RA Capital Management L.P.
Victory Capital Management Inc.
Eagle Asset Management Inc.
Barclays PLC
Barclays PLC
Public Employees Retirement System of Ohio
Exchange Traded Concepts LLC
Which institutional investors are buying iTeos Therapeutics stock?: During the last quarter, ITOS stock was purchased by institutional investors including:
State Street Corp
Algert Global LLC
Readystate Asset Management LP
Stonepine Capital Management LLC
Jacobs Levy Equity Management Inc.
GSA Capital Partners LLP
Massachusetts Financial Services Co. MA
Geode Capital Management LLC